
Oncology Institute Inc
TOINASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$4.66
Day High
$4.90
Day Low
$4.66
Prev. Close
$4.69
VolumeShares traded today.
1.39M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$477.92M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-12.76
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$4.90
52W LowLowest price over the past 52 weeks.
$2.02
50D MAAverage closing price over the last 50 trading days.
$3.68
200D MAAverage closing price over the last 200 trading days.
$3.48
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+4.1%1M
+23.8%6M
+53.2%YTD
+30.2%1Y
+47.1%About
Mark Scholz is a German-American, double board-certified oncologist and author. He serves as medical director of Prostate Oncology Specialists Inc. in Marina del Rey, CA, a medical practice exclusively focused on prostate cancer. He is also the executive director of the Prostate Cancer Research Institute. He received his medical degree from Creighton University in Omaha, NE. Dr. Scholz completed his Internal Medicine internship and Medical Oncology fellowship at University of Southern California Medical Center.
theoncologyinstitute.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade TOI
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.